Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 33194071!7653635!33194071     free     free     free       Am+J+Transl+Res 2020 ; 12 (10): 6763-6774 Nephropedia Template TP {{tp|p=33194071|t=2020. Progresses in nucleic acid testing for COVID-19 |pdf=|usr=}}{{33194071}} gab.com Text Progresses in nucleic acid testing for COVID-19 JO: Am J Transl Res http://www.kidney.de/pget.php?&tw=1&pmid=33194071 #FOAvip COVID-19 (Coronavirus disease 2019) epidemic has rapidly spread since its outbreak. By 24:00, July 19, China had reported 83,682 confirmed infectious cases of COVID-19, including 4,634 deaths. The prevention and control of COVID-19 remains extremely urgent. Owing to its strong infectivity and onset in populations, early detection of infectious cases of COVID-19 is of great significance to control the epidemic. Nevertheless, clinical experiences in nucleic acid testing (NAT) are limited. False negative results of NAT inconsistent with clinical diagnosis are often reported. Therefore, it is necessary to improve the sensitivity and specificity of NAT. This study aims to summarize the current situation and prospect of NAT application based on the lasted findings on COVID-19 infection. Meanwhile, potential methods are proposed to improve the validity of NAT, like improving sample quality. The review may provide references for clinical and experimental explorations on COVID-19. Twit Text FOAVip Progresses in nucleic acid testing for COVID-19 ????Am J Transl Res http://www.kidney.de/pget.php?&tw=1&pmid=33194071 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33194071 #FOAvip English Wikipedia <ref>{{Cite pmid|33194071}}</ref> Progresses in nucleic acid testing for COVID-19 #MMPMID33194071 Liu K; Xu Z; Mao X; Li T; Wen J Am J Transl Res 2020[]; 12 (10): 6763-6774 PMID33194071show ga COVID-19 (Coronavirus disease 2019) epidemic has rapidly spread since its outbreak. By 24:00, July 19, China had reported 83,682 confirmed infectious cases of COVID-19, including 4,634 deaths. The prevention and control of COVID-19 remains extremely urgent. Owing to its strong infectivity and onset in populations, early detection of infectious cases of COVID-19 is of great significance to control the epidemic. Nevertheless, clinical experiences in nucleic acid testing (NAT) are limited. False negative results of NAT inconsistent with clinical diagnosis are often reported. Therefore, it is necessary to improve the sensitivity and specificity of NAT. This study aims to summarize the current situation and prospect of NAT application based on the lasted findings on COVID-19 infection. Meanwhile, potential methods are proposed to improve the validity of NAT, like improving sample quality. The review may provide references for clinical and experimental explorations on COVID-19. äProgresses in nucleic acid testing for COVID-19 (epmc).pdf DeepDyve Pubget Overpricing